The CDK1 inhibitor RO3306 improves the response of BRCA-proficient breast cancer cells to PARP inhibition

Author:            

Publisher: Spandidos Publications

ISSN: 1019-6439

Source: International Journal of Oncology, Vol.44, Iss.3, 2014-01, pp. : 735-744

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content